Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 0 | 575 | 0 | 0 | 0 |
| Cost of Goods | 4,850 | 257 | N/A | N/A | N/A |
| Gross Profit | -4,850 | 318 | N/A | N/A | N/A |
| Operating Expenses | 61,991 | 85,858 | 66,986 | 64,602 | 63,188 |
| Operating Income | -65,991 | -85,283 | -66,986 | -64,602 | -63,188 |
| Interest Expense | 3,212 | 2,229 | 2,510 | 0 | 1,262 |
| Other Income | 280 | 1,199 | 3,341 | 43 | 1,620 |
| Pre-tax Income | -68,923 | -86,313 | -66,155 | -64,559 | -62,830 |
| Income Tax | 321 | 119 | 743 | -104 | 48 |
| Net Income Continuous | -69,244 | -86,432 | -66,898 | -64,455 | -62,878 |
| Net Income | $-69,244 | $-86,432 | $-66,898 | $-64,455 | $-62,878 |
| EPS Basic Total Ops | -1.06 | -1.34 | -1.06 | -1.03 | -1.01 |
| EPS Basic Continuous Ops | -1.06 | -1.34 | -1.06 | -1.03 | -1.01 |
| EPS Diluted Total Ops | -1.06 | -1.34 | -1.06 | -1.03 | -1.01 |
| EPS Diluted Continuous Ops | -1.06 | -1.34 | -1.06 | -1.03 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -1.06 | -1.18 | -1.06 | -1.03 | -1.01 |
| EBITDA(a) | $-64,544 | $-83,991 | $-65,940 | $-63,850 | $-62,655 |